当前位置：
X-MOL 学术
›
Cancer Biother. Radiopharm.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma
Cancer Biotherapy and Radiopharmaceuticals ( IF 2.4 ) Pub Date : 2022-02-08 , DOI: 10.1089/cbr.2020.4679 Mine Araz 1 , Elgin Özkan 1 , Pınar Gunduz 1 , Cigdem Soydal 1 , N Özlem Küçük 1 , K Metin Kır 1
Cancer Biotherapy and Radiopharmaceuticals ( IF 2.4 ) Pub Date : 2022-02-08 , DOI: 10.1089/cbr.2020.4679 Mine Araz 1 , Elgin Özkan 1 , Pınar Gunduz 1 , Cigdem Soydal 1 , N Özlem Küçük 1 , K Metin Kır 1
Affiliation
Background: The aim was to evaluate: (i) if multifocality is a negative prognostic factor; and (ii) the association of diameter of the largest tumor, total tumor diameter, and the ratio of the largest tumor diameter to total tumor diameter (DR) with histopathological and clinical outcome parameters in T1 differentiated thyroid carcinoma (DTC).
中文翻译：
影响 T1 分化甲状腺癌发病率的阴性组织病理学预后因素
背景：目的是评估：(i) 多灶性是否是负面预后因素；(ii) T1 分化甲状腺癌 (DTC) 中最大肿瘤直径、总肿瘤直径和最大肿瘤直径与总肿瘤直径 (DR) 的比值与组织病理学和临床结果参数的关联。
更新日期：2022-02-09
中文翻译：
影响 T1 分化甲状腺癌发病率的阴性组织病理学预后因素
背景：目的是评估：(i) 多灶性是否是负面预后因素；(ii) T1 分化甲状腺癌 (DTC) 中最大肿瘤直径、总肿瘤直径和最大肿瘤直径与总肿瘤直径 (DR) 的比值与组织病理学和临床结果参数的关联。
京公网安备 11010802027423号